A recent research result has established that a single dose of the Covishield vaccine can reduce the prospects for death by 80%!
England�s General Health Centre conducted a research on the Covishield vaccine manufactured at the Serum Insatiate of India, Pune, India.
The researchers collected extensive data of the patients who died within 28 days of infection after vaccination and conducted a research on the same. After the research, it is established that a single dose of Covishield vaccine reduces the prospects for death by 80%.